Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.04
+0.39 (6.90%)
At close: May 20, 2026, 4:00 PM EDT
6.13
+0.09 (1.48%)
After-hours: May 20, 2026, 6:32 PM EDT

Entrada Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
218394650505424535
Market Cap Growth
-33.46%-39.42%28.76%18.87%-20.60%-
Enterprise Value
12.53144.66281.31212.92253.28243.5
Last Close Price
6.0410.2817.2915.0913.5217.12
PE Ratio
--10.29---
PS Ratio
37.9315.483.083.91--
PB Ratio
0.801.291.522.082.001.79
P/TBV Ratio
0.931.391.572.061.990.36
P/FCF Ratio
---3.76--
P/OCF Ratio
---3.61--
EV/Sales Ratio
2.185.691.331.65--
EV/EBITDA Ratio
--5.54---
EV/EBIT Ratio
--5.98---
EV/FCF Ratio
---1.59--
Debt / Equity Ratio
0.170.150.120.250.080
Debt / EBITDA Ratio
--1.17---
Debt / FCF Ratio
---0.51--
Net Debt / Equity Ratio
-0.76-0.80-0.84-1.17-0.77-0.97
Net Debt / EBITDA Ratio
1.181.59-7.10883.921.715.82
Net Debt / FCF Ratio
1.561.898.07-2.111.685.25
Asset Turnover
0.020.060.420.3600
Quick Ratio
13.3212.1410.732.258.5943.32
Current Ratio
13.9012.5311.152.339.5544.46
Return on Equity (ROE)
-57.58%-39.13%19.56%13.54%-37.01%-30.19%
Return on Assets (ROA)
-50.34%-35.17%9.32%-2.24%-34.86%-29.27%
Return on Invested Capital (ROIC)
-281.03%-211.29%48.50%-10.60%-336.33%-1114.73%
Return on Capital Employed (ROCE)
-53.32%-37.61%11.79%-1.17%-36.75%-30.14%
Earnings Yield
--9.72%---
FCF Yield
---26.59%--
Buyback Yield / Dilution
-2.44%-6.07%-18.01%-5.61%-399.27%-467.09%
Total Shareholder Return
-2.44%-6.07%-18.01%-5.61%-399.27%-467.09%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q